AdaptHealth Corp. (AHCO) vs Candel Therapeutics, Inc. (CADL)
A side-by-side comparison of AdaptHealth Corp. and Candel Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AHCO
AdaptHealth Corp.
$5.77HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CADL
Candel Therapeutics, Inc.
$10.32HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — AHCO vs CADL
growth of $100 · dividends reinvested · last 5yAHCO -74.3% (-23.8%/yr)CADL +46.1% (+7.9%/yr)CADL compounded faster over this window
Log scale — wide-divergence pair
AHCO CADL
AHCO vs CADL: by the numbers
- •AHCO is the larger company ($785M vs $756M market cap).
- •Both run net losses; CADL's is the smaller (0.00% vs -7.58% net margin).
Metrics side by side
Valuation
| Metric | AHCO | CADL |
|---|---|---|
| P/S ratio | 0.26 | N/A |
| P/B ratio | 0.57 | 5.99 |
| EV / EBITDA | 6.63 | N/A |
| FCF yield | 12.44% | N/A |
Profitability
| Metric | AHCO | CADL |
|---|---|---|
| Gross margin | 10.37% | 0.00% |
| Operating margin | -0.31% | 0.00% |
| Net margin | -7.58% | 0.00% |
| ROE | -16.56% | -70.19% |
| ROIC | -0.26% | -36.83% |
Growth (annualized)
| Metric | AHCO | CADL |
|---|---|---|
| Revenue CAGR (5Y) | 11.68% | N/A |
| FCF CAGR (5Y) | 7.07% | N/A |
| Total return CAGR (5Y) | -24.65% | -1.42% |
Frequently asked
- How have AHCO and CADL total returns compared?
- Over the past 5 years, AHCO delivered -24.65% and CADL delivered -1.42% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AdaptHealth ROECandel Therapeutics ROEAdaptHealth operating marginCandel Therapeutics operating marginAdaptHealth revenue growthCandel Therapeutics revenue growthAdaptHealth free cash flowCandel Therapeutics free cash flow
AdaptHealth & Candel Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.